Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.3.3.1 (
citrate synthase
)
4,488
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The yeast CIT1 (mitochondrial
citrate synthase
) gene is subject to glucose repression and is further repressed by glucose plus glutamate. Based on deletion analysis of a CIT1-lacZ gene fusion, DNA sequences between -548 and -273 are required for full expression of CIT1. The region of transcription initiation and the putative TATA element are located at -150 to -100 and -195 respectively. A restriction fragment containing DNA sequences between -457 and -211 conferred activation and glucose-glutamate regulation when placed in either orientation upstream of a UAS-less heterologous yeast gene. Deletion of DNA sequences between -291 and -273 specifically eliminated derepression of CIT1, and destroyed one of two closely-spaced, potential binding sites for the
HAP2
,3,4 transcriptional activator protein. Ten-base-pair block substitutions in the region -367 to -348 reduced glucose-repressed expression. Thus, it appears that distinct DNA sequences upstream of CIT1 activate expression in glucose-repressed and derepressed cells. Possible mechanisms of regulation by glutamate plus glucose, are discussed.
...
PMID:Distinct upstream activation regions for glucose-repressed and derepressed expression of the yeast citrate synthase gene CIT1. 792 3
The yeast nuclear gene CIT1 encodes mitochondrial
citrate synthase
, which catalyses the first and rate-limiting step of the tricarboxylic acid (TCA) cycle. Transcription of CIT1 is subject to glucose repression. Mutations in
HAP2
, HAP3 or HAP4 block derepression of a CIT1-lacZ gene fusion. The
HAP2
,3,4 transcriptional activator also activates nuclear genes encoding components of the mitochondrial electron transport chain, and thus it co-ordinates derepression of two major mitochondrial functions. Two DNA sequences resembling the consensus
HAP2
,3,4-binding site (ACCAATNA) are located at approximately -310 and -290, upstream of the CIT1 coding sequence. Deletion and mutation analysis indicates that the -290 element is critical for activation by
HAP2
,3,4. Glucose-repressed expression of CIT1 is largely independent of
HAP2
,3,4, is repressed by glutamate, and requires a DNA sequence between -367 and -348. Evidence is presented for a second
HAP2
,3,4-independent activation element located just upstream and overlapping the -290
HAP2
,3,4 element.
...
PMID:The HAP2,3,4 transcriptional activator is required for derepression of the yeast citrate synthase gene, CIT1. 798 86